Physician

James Griffith, M.D.

According to 2025 Medicare claims, James Griffith, M.D. (NPI: 1669815452) practices dermatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is DERMATOLOGY AND SKIN CANCER SPECIALISTS, LLC (NPI: 1205880846; TIN: 861072868) and primary practice location at 66211-1453.

Griffith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 933 traditional Medicare patients, billed 5,454 HCPCS/CPT codes, and received $633,199 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 972 prescription claims across 485 beneficiaries totaling $58,487 in drug costs, led by Erivedge (Vismodegib). Open Payments data shows 62 records totaling $1,586. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $31,292 and ending at $58,487. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	299	1,227	$357,802
2020	333	1,475	$384,699
2021	283	957	$246,822
2022	545	3,724	$426,669
2023	712	4,768	$493,892
2024	933	5,454	$633,199

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	69	126	$31,292
2016	163	501	$92,278
2017	154	444	$51,101
2018	102	231	$53,737
2019	232	353	$10,947
2020	300	499	$151,620
2021	165	267	$19,321
2022	228	346	$38,997
2023	376	717	$64,957
2024	485	972	$58,487

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	328	434	$462
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	323	$94
17110	Destruction of skin growth, 1-14 growths	237	293	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	471	653	$64
17000	Destruction of precancer skin growth, 1 growth	279	366	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erivedge	Vismodegib	12	360	$30,491
Fluorouracil	Fluorouracil	77	2,482	$4,940
Clobetasol Propionate	Clobetasol Propionate	79	2,237	$3,401
Doxycycline Hyclate	Doxycycline Hyclate	65	1,882	$2,188
Minocycline Hcl	Minocycline Hcl	154	2,007	$1,726

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,586	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Griffith, M.D.?

Tedicare shows public-source Medicare data for James Griffith, M.D. (NPI 1669815452), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Griffith, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Griffith, M.D.?

James Griffith, M.D. is linked to DERMATOLOGY AND SKIN CANCER SPECIALISTS, LLC (billing NPI 1205880846) in the available physician profile data.

Does James Griffith, M.D. have Open Payments data?

James Griffith, M.D. has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.